HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yogesh Patel Selected Research

Myocardial Infarction

4/2012Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yogesh Patel Research Topics

Disease

3Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
03/2024 - 01/2022
3Neoplasms (Cancer)
10/2023 - 10/2010
2Tuberculosis (Tuberculoses)
01/2024 - 01/2017
1Fatigue
10/2023
1Chronic Disease (Chronic Diseases)
10/2023
1Pain (Aches)
09/2023
1Clubfoot (Talipes Equinovarus)
01/2023
1Heart Failure
11/2022
1Bone Marrow Failure Disorders
01/2022
1Hemolysis
01/2022
1Medulloblastoma
01/2022
1COVID-19
08/2021
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2020
1Infections
05/2015
1Inflammation (Inflammations)
05/2015
1Coronary Artery Disease (Coronary Atherosclerosis)
02/2015
1Hepatitis A (Hepatitis, Infectious)
01/2015
1Pathologic Constriction (Stenosis)
06/2014
1Ventricular Heart Septal Defects (Ventricular Septal Defect)
02/2014
1Cardiovascular Diseases (Cardiovascular Disease)
06/2012
1Thrombosis (Thrombus)
04/2012
1Myocardial Infarction
04/2012
1Fibrosis (Cirrhosis)
10/2010
1Cholangiocarcinoma
10/2010
1Obstructive Jaundice (Cholestatic Jaundice)
10/2010
1Hypertension (High Blood Pressure)
05/2003
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2002
1Hypoxia (Hypoxemia)
12/2002

Drug/Important Bio-Agent (IBA)

2Hemoglobins (Hemoglobin)IBA
03/2024 - 01/2022
2eculizumabFDA Link
10/2023 - 01/2022
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2024
1VaccinesIBA
01/2024
1ravulizumabIBA
10/2023
1Complement Inactivating AgentsIBA
10/2023
1N-(4-isothiocyanatophenethyl)spiperoneIBA
09/2023
1DiureticsIBA
11/2022
1Soluble Guanylyl CyclaseIBA
11/2022
1vericiguatIBA
11/2022
1ribociclibIBA
01/2022
1GemcitabineFDA Link
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1Complement C5 (Complement 5)IBA
01/2022
1mesoglycanIBA
08/2021
1bedaquiline (R207910)IBA
01/2020
1LactoferrinIBA
05/2015
1CreatinineIBA
02/2015
1Linoleic Acid (Linoleate)IBA
01/2015
1Fetal Proteins (Fetoprotein)IBA
10/2010
1EnzymesIBA
05/2003
1Superoxide DismutaseIBA
12/2002
1CopperIBA
12/2002
1Neuroprotective AgentsIBA
12/2002
1Interferon-gamma (Interferon, gamma)IBA
12/2002
1ZincIBA
12/2002
1StaurosporineIBA
12/2002

Therapy/Procedure

3Percutaneous Coronary Intervention
02/2015 - 06/2012
2Therapeutics
10/2023 - 01/2017
1Pacifiers
09/2023
1Tenotomy
01/2023
1Art Therapy
01/2017
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2014
1Prostheses and Implants (Prosthesis)
02/2014
1Transcatheter Aortic Valve Replacement
02/2014
1Stents
04/2012